Sign in

ExlService Holdings, Inc. EXLS

Price 37.3 USD
as of 2026-09-04
59/100
Constructive
Quality59
Growth70
Balance-sheet strength64
Valuation60
Momentum45
Income50

Composite 59/100; the shares have moved about 44% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 45/100 — a slight mark against it.

Case for

Growth ranks 70/100 — a moderate point in its favour. Balance-sheet strength ranks 64/100 — a moderate point in its favour. Valuation ranks 60/100 — a slight point in its favour.

Case against

Momentum ranks 45/100 — a slight mark against it.

What the company does ExlService Holdings provides AI and data-driven operations and analytics services across insurance, healthcare, banking, and diversified industries. Its platforms include LifePRO for digital customer acquisition and Subrosource for end-to-end subrogation.

Key financials EXLS posts strong profitability metrics: ROE 28.1%, ROA 12.2%, ROCE 25.9%, and net margin 11.7%. Revenue grew 13.8% while EPS grew 7.5%. Debt/Equity is 0.57 with interest coverage of 11.92x.

Stock health Momentum is weak: -18.58% over 12m and -27.06% from the 52-week high, with RSI at 69.80. Sideravia scores Quality 67.9 and Strength 74.9 but Momentum only 30.2.

Price vs fair value The stock trades at a **discount** of 41.50% to our fair-value estimate and a **discount** of 16.78% to the analyst 12-month target. - Strong Q2 results and raised guidance highlighted by multiple outlets (Zacks, GuruFocus, MarketBeat) - iMerit deal cited as a catalyst for growth and valuation (Simply Wall St.) - Hedge fund confidence noted after rally (Insider Monkey) - Comparisons to peers suggesting relative value (Zacks)

Looking forward Forward P/E of 12.41 and PEG of 0.30 suggest undemanding valuation, but momentum remains a concern. Analysts see 16.78% upside to the 12-month target.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.